The website also takes issue with this line in the paper: "mRNA vaccines and their manufacturing process are a novel technology, and the resulting products differ from other types of vaccines". It ...

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

In its earnings release on Friday, Moderna (NASDAQ:MRNA) said it would focus on driving sales this year and deliver up to 10 product approvals until 2027. “By the end of 2025, we aim to remove ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – ...

Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood ...

Feb. 14—A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of committee in a party-line vote Wednesday. Sponsored by Rep.

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

Learn about Altamira and Divincell's cutting-edge formulation techniques for thermostable mRNA products, which reduce cold chain dependencies and increase global accessibility. Do not pass up the ...

We will continue to focus on delivering the greatest possible impact to people through mRNA medicines. Our portfolio of products and pipeline are progressing well. Two approved products ...

mRESVIA ® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...